• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd

Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

Pfizer
Favicon Fierce Biotech

A 5-month sprint: Inside Pfizer's $10B deal with Innovent

Leveraging interest from other parties, Innovent at one point threatened to walk away if Pfizer didn’t agree to its co-development terms.
Angus Liu Jun 21, 2026 10:41pm
Sign on doorway for FTC in Washington DC

Aurobindo must divest 4 drugs to complete Lannett buyout: FTC

Jun 18, 2026 3:45pm
graphic image of China flags overlapping with US flags
Favicon Fierce Biotech

Will COINS Act kill China biotech licensing boom?

May 26, 2026 3:50pm
Astellas
Favicon Fierce Biotech

Astellas targets more deals, cost cutting to swerve patent cliff

May 26, 2026 7:35am
Gilead

Gilead, WHO expand antiparasitic collab

May 21, 2026 11:18am
merger MA unit combine consolidate deal

Chiesi grows rare disease ambitions with $1.9B KalVista buyout

Apr 29, 2026 10:01am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings